Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You and Your Team.

Learn More →

Human Papillomavirus Vaccine and Sexual Activity

Human Papillomavirus Vaccine and Sexual Activity Research Original Investigation STIs After HPV Vaccination Invited Commentary How Do We Best Address Parent and Physician Concerns? Robert A. Bednarczyk, PhD Compared with other routinely recommended adolescent vac- ter adjustment for preindex quarter STI risk. This pattern was cines (eg, diphtheria and tetanus toxoids and acellular pertus- consistent after stratification by age and restriction to adoles- sis [Tdap] vaccine and quadrivalent meningococcal conju- cent females with insurance claims for contraceptives in their gate [MCV4] vaccine), human papillomavirus (HPV) vaccine vaccine index quarter. These subanalyses indicate that even uptake has been lower, with among those who may have already been sexually active, sexual only 57% of adolescent fe- activity levels, as measured by incidence of STIs, did not in- Related article page 617 males and 35% of adolescent crease after HPV vaccination. males initiating the 3-dose These findings should not come as a surprise to research- HPV vaccine series. Often, the reasons cited for these low HPV ers in the field of HPV vaccinology and should serve as con- vaccination rates pertain to the vaccine’s role in preventing a tinued reassurance that HPV vaccination does not lead to sexual sexually transmitted infection (STI). Parents commonly indi- disinhibition. However, this http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png JAMA Internal Medicine American Medical Association

Human Papillomavirus Vaccine and Sexual Activity

JAMA Internal Medicine , Volume 175 (4) – Apr 1, 2015

Loading next page...
 
/lp/american-medical-association/human-papillomavirus-vaccine-and-sexual-activity-64X210rj0D
Publisher
American Medical Association
Copyright
Copyright 2015 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.
ISSN
2168-6106
eISSN
2168-6114
DOI
10.1001/jamainternmed.2014.7894
pmid
25664447
Publisher site
See Article on Publisher Site

Abstract

Research Original Investigation STIs After HPV Vaccination Invited Commentary How Do We Best Address Parent and Physician Concerns? Robert A. Bednarczyk, PhD Compared with other routinely recommended adolescent vac- ter adjustment for preindex quarter STI risk. This pattern was cines (eg, diphtheria and tetanus toxoids and acellular pertus- consistent after stratification by age and restriction to adoles- sis [Tdap] vaccine and quadrivalent meningococcal conju- cent females with insurance claims for contraceptives in their gate [MCV4] vaccine), human papillomavirus (HPV) vaccine vaccine index quarter. These subanalyses indicate that even uptake has been lower, with among those who may have already been sexually active, sexual only 57% of adolescent fe- activity levels, as measured by incidence of STIs, did not in- Related article page 617 males and 35% of adolescent crease after HPV vaccination. males initiating the 3-dose These findings should not come as a surprise to research- HPV vaccine series. Often, the reasons cited for these low HPV ers in the field of HPV vaccinology and should serve as con- vaccination rates pertain to the vaccine’s role in preventing a tinued reassurance that HPV vaccination does not lead to sexual sexually transmitted infection (STI). Parents commonly indi- disinhibition. However, this

Journal

JAMA Internal MedicineAmerican Medical Association

Published: Apr 1, 2015

References